NCT04861948 2022-10-04
IBI188 Combination Therapy in Solid Tumors
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1 Terminated
Innovent Biologics (Suzhou) Co. Ltd.
Helix BioPharma Corporation
Radiation Therapy Oncology Group
SWOG Cancer Research Network
National Cancer Institute (NCI)